Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Myeloperoxidase as therapeutic target in HFpEF

Autor: S Lejeune, A Ginion, N Menghoum, S Horman, C Beauloye, A C Pouleur

Publikováno v: European Heart Journal. 43

Background Inflammation and oxidative stress are thought to play an important role in the pathophysiology of HFpEF through the development of endothelial dysfunction. Myeloperoxidase (MPO), a leukocyte-derived enzyme, functions as a link between oxid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::618a963f6a74009c9e7e358e7ec7360f
https://doi.org/10.1093/eurheartj/ehac544.762

Impact of recent 2021 ESC guideline changes on postoperative survival of patients with severe aortic regurgitation: insights from the AVIATOR registry

Autor: V Hanet, D De Azevedo, P Krug, H J Schafers, E Lansac, L De Kerchove, I El-Hamamsy, J Vojacek, M Contino, A C Pouleur, C Beauloye, A Pasquet, J L Vanoverschelde, D Vancraeynest, B Gerber

Publikováno v: European Heart Journal. 43

Background Until 2021, the strongest guidelines on surgical correction of severe aortic regurgitation (AR) focused on the left ventricular systolic function (LVEF) and the presence of symptoms. However, those situations lead to an outcome penalty, ev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2fae8fe7c958d92afde2ba8c7a5f85ba
https://doi.org/10.1093/eurheartj/ehac544.129

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical and Hemodynamic Effects of Percutaneous Edge-to-Edge Mitral Valve Repair in Atrial Versus Ventricular Functional Mitral Regurgitation

Autor: Patrick Coussement, Philippe Debonnaire, C M Van De Heyning, Bert Ferdinande, Bernard Cosyns, Marc Vanderheyden, Bernard P. Paelinck, Patrizio Lancellotti, J Vanderheyden, Giada Bilotta, A C Pouleur, Christophe Dubois, Nikol Shkarpa, V Bracke, Marc J. Claeys

Publikováno v: The American journal of cardiology, Vol. 161, no.Dec 15, p. 70-75 (2021)
The American journal of cardiology, Vol. 161, p. 70-75 (2021)
The American journal of cardiology
Web of Science

Background Atrial functional mitral regurgitation (A-FMR) is a novel entity characterized by a MR due to atrial remodeling but with preserved left ventricular (LV) systolic function. Purpose To assess the clinical and haemodynamic impact of percutane

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7883ba03a5de739694222bc8b6d83e6e
https://hdl.handle.net/2078.1/262935